Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco-Príeto MJ. Estella-Hermoso de Mendoza A, et al. Among authors: campanero ma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):4035-41. doi: 10.1016/j.jchromb.2009.10.020. Epub 2009 Oct 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19896423
Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography-electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems.
Blanco-Príeto MJ, Campanero MA, Mollinedo F. Blanco-Príeto MJ, et al. Among authors: campanero ma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 15;810(1):85-92. doi: 10.1016/j.jchromb.2004.07.013. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15358311 Free article.
Lipid nanomedicines for anticancer drug therapy.
Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco-Prieto MJ. Estella-Hermoso de Mendoza A, et al. Among authors: campanero ma. J Biomed Nanotechnol. 2009 Aug;5(4):323-43. doi: 10.1166/jbn.2009.1042. J Biomed Nanotechnol. 2009. PMID: 20055079 Review.
In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, Roué G, Gil J, Colomer D, Campanero MA, Blanco-Prieto MJ. Mollinedo F, et al. Among authors: campanero ma. Clin Cancer Res. 2010 Apr 1;16(7):2046-54. doi: 10.1158/1078-0432.CCR-09-2456. Epub 2010 Mar 16. Clin Cancer Res. 2010. PMID: 20233887 Free article.
Lipid raft-targeted therapy in multiple myeloma.
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, Blanco-Prieto MJ. Mollinedo F, et al. Among authors: campanero ma. Oncogene. 2010 Jul 1;29(26):3748-57. doi: 10.1038/onc.2010.131. Epub 2010 Apr 26. Oncogene. 2010. PMID: 20418917
72 results